Bar Harbor Biotechnology has contributed to some exciting discoveries over the past two years. As we prepare to launch XenoQ™ Assays, that will change how drug discovery companies do gene expression research, we wish to thank all the early explorers that made our system such a success.

Our flagship products, The StellARray™ Gene Expression System will continue to be sold through our exclusive sales agreement with Lonza. Its combination of GeneSieve™ bioinformatics, StellARray™ Real-Time PCR arrays, and Global Pattern Recognition™ bioanalysis software will change the way gene expression experiments are done.

The NEW XenoQ™ Assays are now available. These quantitive PCR assays measure human gene expression and gene copy number variations with no cross reactivity from a mouse vehicle in a xenograft experiment. Click here to read more about the benefits of XenoQ™ Assays.

We are very proud to announce the acquisition of the commercial service license for quantitative PCR. Our new services will offer our years of experience and expertise in designing, testing and running your qPCR experiments. Read more about our NEW qPCR Services here.

Follow this link to the Lonza website to learn how:

• GeneSieve™ designs experiments in the context of your biological research.
• StellARrays™ quantitate gene expression and gene copy number.
• Global Pattern Recognition™ eliminates pre-selecting a normalizer gene.

Click here for a presentation about The StellARray™ Gene Expression System.